awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35603183-EF2A064D-68E7-4248-B67D-0347E979EF08
Q35603183-EF2A064D-68E7-4248-B67D-0347E979EF08
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35603183-EF2A064D-68E7-4248-B67D-0347E979EF08
Sorafenib inhibits intracellular signaling pathways and induces cell cycle arrest and cell death in thyroid carcinoma cells irrespective of histological origin or BRAF mutational status
P2860
Q35603183-EF2A064D-68E7-4248-B67D-0347E979EF08
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35603183-EF2A064D-68E7-4248-B67D-0347E979EF08
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fbe410c1a83ed66b6aa83882efdc93696ed24fbf
P2860
Rationale and design of decision: a double-blind, randomized, placebo-controlled phase III trial evaluating the efficacy and safety of sorafenib in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory, differentiated thyr